SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Annacarmen Petrizzo, Maria Tagliamonte, Marialina Tornesello, Franco M Buonaguro, Luigi Buonaguro, Systems vaccinology for cancer vaccine development, Expert Review of Vaccines, 2014, 13, 6, 711

    CrossRef

  2. 2
    Lingxiao Zhao, Min Zhang, Hua Cong, Advances in the study of HLA-restricted epitope vaccines, Human vaccines & immunotherapeutics, 2013, 9, 12, 2566

    CrossRef

  3. 3
    A. Patronov, I. Doytchinova, T-cell epitope vaccine design by immunoinformatics, Open Biology, 2013, 3, 1, 120139

    CrossRef

  4. 4
    Stine Kiaer Larsen, Morten Hansen, Inge Marie Svane, Per Thor Straten, Mads Hald Andersen, Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot, Cells, 2012, 1, 4, 51

    CrossRef

  5. 5
    Shamaila Munir, Thomas Mørch Frøsig, Morten Hansen, Inge Marie Svane, Mads Hald Andersen, Characterization of T-cell responses against IκBα in cancer patients, OncoImmunology, 2012, 1, 8, 1290

    CrossRef

  6. 6
    Rikke Sick Andersen, Rikke Bæk Sørensen, Cathrin Ritter, Inge Marie Svane, Jürgen C. Becker, Per thor Straten, Mads Hald Andersen, Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors, Cancer Immunology, Immunotherapy, 2011, 60, 2, 227

    CrossRef

  7. 7
    Claus Lundegaard, Ole Lund, Morten Nielsen, Prediction of epitopes using neural network based methods, Journal of Immunological Methods, 2011, 374, 1-2, 26

    CrossRef

  8. 8
    Claus Lundegaard, Ole Lund, Søren Buus, Morten Nielsen, Major histocompatibility complex class I binding predictions as a tool in epitope discovery, Immunology, 2010, 130, 3
  9. 9
    Kajsa Lundberg, Anna-Karin Roos, Maxim Pavlenko, Christoph Leder, Diana Wehrum, José Guevara-Patiño, Rikke Sick Andersen, Pavel Pisa, A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols, Vaccine, 2009, 27, 10, 1557

    CrossRef

  10. 10
    Uthaman Gowthaman, Javed N Agrewala, In silicomethods for predicting T-cell epitopes: Dr Jekyll or Mr Hyde?, Expert Review of Proteomics, 2009, 6, 5, 527

    CrossRef

  11. 11
    Carla Herrera-Najera, Raúl Piña-Aguilar, Fiona Xacur-Garcia, Maria Jesus Ramirez-Sierra, Eric Dumonteil, Mining the Leishmania genome for novel antigens and vaccine candidates, PROTEOMICS, 2009, 9, 5
  12. 12
    Lynn Wenandy, Rikke Bæk Sørensen, Inge Marie Svane, Per thor Straten, Mads Hald Andersen, RhoC a new target for therapeutic vaccination against metastatic cancer, Cancer Immunology, Immunotherapy, 2008, 57, 12, 1871

    CrossRef

  13. 13
    Noah Zaitlen, Manuel Reyes-Gomez, David Heckerman, Nebojsa Jojic, Shift-Invariant Adaptive Double Threading: Learning MHC II–Peptide Binding, Journal of Computational Biology, 2008, 15, 7, 927

    CrossRef

  14. 14
    Anthony W. Purcell, James McCluskey, Jamie Rossjohn, More than one reason to rethink the use of peptides in vaccine design, Nature Reviews Drug Discovery, 2007, 6, 5, 404

    CrossRef

  15. 15
    Wei Li, Heng Cui, Fan-Qiang Meng, Xiao-Hong Chang, Guo Zhang, Bei Liu, Zi-Hai Li, New T cell epitopes identified from an anti-idiotypic antibody mimicking ovarian cancer associated antigen, Cancer Immunology, Immunotherapy, 2007, 57, 2, 143

    CrossRef

  16. 16
    Gregory A. Stoloff, Wilson Caparros-Wanderley, Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes, European Journal of Immunology, 2007, 37, 9
  17. 17
    Tal Vider-Shalit, Shai Raffaeli, Yoram Louzoun, Virus-epitope vaccine design: Informatic matching the HLA-I polymorphism to the virus genome, Molecular Immunology, 2007, 44, 6, 1253

    CrossRef

  18. 18
    Marta Gomez-Nunez, Javier Pinilla-Ibarz, Tao Dao, Rena J. May, Mary Pao, Jaspreet S. Jaggi, David A. Scheinberg, Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules, Leukemia Research, 2006, 30, 10, 1293

    CrossRef

  19. 19
    Yoram Louzoun, Tal Vider, Martin Weigert, T-cell epitope repertoire as predicted from human and viral genomes, Molecular Immunology, 2006, 43, 6, 559

    CrossRef

  20. 20
    Judith M. Ramage, Ian Spendlove, Robert Rees, Robert S. Moss, Lindy G. Durrant, The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2, Cancer Immunology, Immunotherapy, 2006, 55, 8, 1004

    CrossRef

  21. 21
    Z. Nyárády, T. Czömpöly, Sz. Bősze, G. Nagy, Á. Petrohai, J. Pál, F. Hudecz, T. Berki, P. Németh, Validation of in silico prediction by in vitro immunoserological results of fine epitope mapping on citrate synthase specific autoantibodies, Molecular Immunology, 2006, 43, 7, 830

    CrossRef

  22. 22
    Taiki Aoshi, Mina Suzuki, Masato Uchijima, Toshi Nagata, Yukio Koide, Expression mapping using a retroviral vector for CD8+ T cell epitopes: Definition of a Mycobacterium tuberculosis peptide presented by H2-Dd, Journal of Immunological Methods, 2005, 298, 1-2, 21

    CrossRef

  23. 23
    M H Andersen, P Kvistborg, J C Becker, P thor Straten, Identification of an HLA-A1 restricted CTL epitope from Mcl-1, Leukemia, 2005, 19, 6, 1084

    CrossRef

  24. 24
    Anders Meier, Sine Reker, Inge Marie Svane, Lars Holten-Andersen, J�rgen C. Becker, Ib S�ndergaard, Mads Hald Andersen, Per Straten, Spontaneous T-cell responses against peptides derived from the Taxol resistance?associated gene-3 (TRAG-3) protein in cancer patients, Cancer Immunology, Immunotherapy, 2005, 54, 3, 219

    CrossRef

  25. 25
    Nicholas A Williamson, Anthony W Purcell, Use of proteomics to define targets of T-cell immunity, Expert Review of Proteomics, 2005, 2, 3, 367

    CrossRef

  26. 26
    Vasso Apostolopoulos, Eliada Lazoura, Noncanonical peptides in complex with MHC class I, Expert Review of Vaccines, 2004, 3, 2, 151

    CrossRef

  27. 27
    Mads Hald Andersen, Sine Reker, Jurgen C. Becker, Per thor Straten, The Melanoma Inhibitor of Apoptosis Protein: A Target for Spontaneous Cytotoxic T Cell Responses, Journal of Investigative Dermatology, 2004, 122, 2, 392

    CrossRef

  28. You have free access to this content28
    Anthony W. Purcell, Weiguang Zeng, Nicole A. Mifsud, Lauren K. Ely, Whitney A. Macdonald, David C. Jackson, Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design, Journal of Peptide Science, 2003, 9, 5
  29. 29
    Darren R. Flower, Towards in silico prediction of immunogenic epitopes, Trends in Immunology, 2003, 24, 12, 667

    CrossRef

  30. 30
    Stuart J Rodda, Peptide libraries for T cell epitope screening and characterization, Journal of Immunological Methods, 2002, 267, 1, 71

    CrossRef

  31. 31
    Andreas O. Eggert, Jürgen C. Becker, Michael Ammon, Alexander D. McLellan, German Renner, Angela Merkel, Eva-B. Bröcker, Eckhart Kämpgen, Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture, European Journal of Immunology, 2002, 32, 1
  32. 32
    Austin L. Hughes, Evolutionary change of predicted cytotoxic T cell epitopes of dengue virus, Infection, Genetics and Evolution, 2001, 1, 2, 123

    CrossRef

  33. 33
    Kenta Nakai, Review: Prediction of in Vivo Fates of Proteins in the Era of Genomics and Proteomics, Journal of Structural Biology, 2001, 134, 2-3, 103

    CrossRef

  34. 34
    Gregory A. Poland, Inna G. Ovsyannikova, Kenneth L. Johnson, Stephen Naylor, The role of mass spectrometry in vaccine development, Vaccine, 2001, 19, 17-19, 2692

    CrossRef